CMP PHARMA INC
GenericsCMP PHARMA INC is a generic drug manufacturer focused on Immunology, Dermatology.
CMP PHARMA INC's Key Drugs
CMP PHARMA INC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
CMP PHARMA INC's Recent FDA Approvals
New NDA/BLA approvals for CMP PHARMA INC over the last two years — novel drugs only, excluding generics and label supplements.
CMP PHARMA INC's Therapeutic Areas
CMP PHARMA INC's approved drugs and pipeline span 2 therapeutic areas, led by Immunology and Dermatology, across 0 biologic and 0 small-molecule drugs. Weighted by commercial stage — approved drugs count most, then late-stage trials.
CMP PHARMA INC's Top Competitors
CMP PHARMA INC's closest competitors by therapeutic-area and drug-target overlap include Pfizer, Eli Lilly, and BAUSCH. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
CMP PHARMA INC Pipeline Snapshot
Active clinical trials for CMP PHARMA INC across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Immunology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1982-12-08
- Latest
- 2025-02-05
- Applications
- 5